Sponsor: 
Pfizer Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in children aged ≥8 weeks and in adults.

MenC — monovalent meningococcal serogroup C–tetanus toxoid conjugate vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 10 µg Neisseria meningitidis serogroup C
  • 10–20 µg tetanus toxoid protein

Adsorbed onto 1.4 mg aluminium hydroxide.

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018